Calithera Biosciences, Inc.
CALA
$0.0001
$0.000.00%
OTC PK
| 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | 0.00 |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | 0.00 |
| Cost of Revenue | 4.76M | 6.45M | 7.76M | 9.57M | 13.74M |
| Gross Profit | -4.76M | -6.45M | -7.76M | -9.57M | -13.74M |
| SG&A Expenses | 2.58M | 3.08M | 3.62M | 4.26M | 4.59M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.35M | 9.53M | 11.38M | 13.83M | 69.21M |
| Operating Income | -7.35M | -9.53M | -11.38M | -13.83M | -69.21M |
| Income Before Tax | -6.94M | -9.80M | -9.08M | -13.84M | -69.21M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -6.94M | -9.80M | -9.08M | -13.84M | -69.21M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.94M | -9.80M | -9.08M | -13.84M | -69.21M |
| EBIT | -7.35M | -9.53M | -11.38M | -13.83M | -69.21M |
| EBITDA | -7.28M | -9.46M | -11.31M | -13.76M | -69.14M |
| EPS Basic | -1.42 | -2.01 | 1.63 | -3.17 | -18.45 |
| Normalized Basic EPS | -0.89 | -1.26 | -1.17 | -2.20 | -11.53 |
| EPS Diluted | -1.42 | -2.01 | -1.59 | -3.17 | -18.45 |
| Normalized Diluted EPS | -0.89 | -1.26 | -1.00 | -2.20 | -11.53 |
| Average Basic Shares Outstanding | 4.87M | 4.87M | 4.86M | 3.93M | 3.75M |
| Average Diluted Shares Outstanding | 4.87M | 4.87M | 5.70M | 3.93M | 3.75M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |